These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9148272)

  • 1. [Influence on extratumoral organ activities of tumor-affinity samarium-153 preparations].
    Schomäcker K; Hebrank H; Scheidhauer K; Scharl A; Saccavini JC; Shukla SK; Franke WG; Schicha H
    Nuklearmedizin; 1997 Mar; 36(2):47-51. PubMed ID: 9148272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biokinetics of tumor-affinity yttrium preparations--2].
    Schomäcker K; Hientzsch B; Franke WG; Scheidhauer K; Scharl A; Jantsch K; Shukla SK; Limouris G; Fischer T; Schicha H
    Nuklearmedizin; 1995 Oct; 34(5):207-14. PubMed ID: 7479096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of ethylenediamine tetramethylene phosphonic acid in normal bone after multiple applications. A non-human primate study.
    Dormehl IC; Louw WK; Schneeweiss FH; Milner R; Schmitt G; Carl U; Croft SA
    Arzneimittelforschung; 1998 Apr; 48(4):408-14. PubMed ID: 9608885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biokinetics of tumor-affinity yttrium preparations--Part 1].
    Schomäker K; Hientzsch B; Franke WG; Scheidhauer K; Scharl A; Jantsch K; Shukla SK; Limouris G; Schicha H
    Nuklearmedizin; 1995 Feb; 34(1):32-9. PubMed ID: 7724362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
    Shi B; Fu Z; Lei XH
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):423-6. PubMed ID: 10920873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Samarium-153-EDTMP biodistribution and dosimetry estimation.
    Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F
    J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
    Singh A; Holmes RA; Farhangi M; Volkert WA; Williams A; Stringham LM; Ketring AR
    J Nucl Med; 1989 Nov; 30(11):1814-8. PubMed ID: 2478681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model.
    Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A
    Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats.
    Láznícek M; Láznícková A; Budský F; Prokop J; Kopicka K
    Appl Radiat Isot; 1994 Sep; 45(9):949-53. PubMed ID: 7951182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.
    Goeckeler WF; Stoneburner LK; Kasi LP; Fossella FV; Price DR; Fordyce WA
    Nucl Med Biol; 1993 Jul; 20(5):657-61. PubMed ID: 8358352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of bone-seeking metal salts on the biodistribution of tumor-seeking heavy metal complexes].
    Schomäcker K; Franke WG; Weiss S; Lindner L; Jantsch K; Shukla SK; Limouris GS
    Nuklearmedizin; 1993 Feb; 32(1):27-33. PubMed ID: 8464757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
    Bayouth JE; Macey DJ; Kasi LP; Fossella FV
    J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.
    Logan KW; Volkert WA; Holmes RA
    J Nucl Med; 1987 Apr; 28(4):505-9. PubMed ID: 3572536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the preparation and stability of samarium-153 propylene diamine tetramethylene phosphonate (PDTMP) complex as a bone seeker.
    Majali MA; Mathakar AR; Shimpi HH; Banerjee S; Samuel G
    Appl Radiat Isot; 2000 Dec; 53(6):987-91. PubMed ID: 11077962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.
    Goeckeler WF; Edwards B; Volkert WA; Holmes RA; Simon J; Wilson D
    J Nucl Med; 1987 Apr; 28(4):495-504. PubMed ID: 3572535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice. The ISOLDE Collaboration.
    Beyer GJ; Offord R; Künzi G; Aleksandrova Y; Ravn U; Jahn S; Barker J; Tengblad O; Lindroos M
    Nucl Med Biol; 1997 Jul; 24(5):367-72. PubMed ID: 9290069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Samarium-153 chelate localization in malignant melanoma.
    Turner JH; Martindale AA; de Witt GC; Webb J; Sorby P; Boyd RE
    Eur J Nucl Med; 1987; 13(8):432-8. PubMed ID: 3125053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation absorbed dose calculations for samarium-153-EDTMP localized in bone.
    Heggie JC
    J Nucl Med; 1991 May; 32(5):840-4. PubMed ID: 2022993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Samarium-153-EDTMP in bone metastases.
    Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of ethylenediaminetetramethylenephosphonate on the biodistribution of tumor-seeking radionuclides].
    Schomäcker K; Franke WG; Mäding P; Shukla SK; Weiss S; Limouris GS; Jantsch K
    Nuklearmedizin; 1993 Feb; 32(1):23-6. PubMed ID: 8464756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.